SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Mar 12, 2013
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: March 12, 2013 · CIK: 0001433607 · Accession: 0001144204-13-014623
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-184066
Letter
InspireMD, Inc.
4 Menorat Hamaor St.
Tel Aviv, Israel 67448
March 12, 2013
VIA EDGAR AND FACSIMILE
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Ms. Amanda Ravitz
Re: InspireMD, Inc.
Registration Statement on Form S-1, originally filed on September 24, 2012
File No. 333-184066, as amended (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern Time, on March 14, 2013, or as soon thereafter as practicable.
In connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company acknowledges the following:
· should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very truly yours,
InspireMD, Inc.
Show Raw Text
CORRESP
1
filename1.htm
InspireMD, Inc.
4 Menorat Hamaor St.
Tel Aviv, Israel 67448
March 12, 2013
VIA EDGAR AND FACSIMILE
U.S. Securities and Exchange
Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Ms. Amanda Ravitz
Re:
InspireMD, Inc.
Registration Statement on Form S-1, originally filed on September 24, 2012
File No. 333-184066, as amended (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461
promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”) hereby respectfully
requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern
Time, on March 14, 2013, or as soon thereafter as practicable.
In connection with
the Company’s request for acceleration of the effective date of the Registration Statement, the Company acknowledges the
following:
· should the U.S. Securities and Exchange Commission (the
“Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective,
it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure
in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should any member of
the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and
Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very truly yours,
InspireMD, Inc.
By:
/s/ Alan Milinazzo
Alan
Milinazzo
Chief Executive Officer